Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 9/2005

01-09-2005 | Original Paper

In vivo detection of metabolic changes by 1 H-MRS in the DEN-induced hepatocellular carcinoma in wistar rat

Authors: Wei-Dong Zhao, Sheng Guan, Kang-Rong Zhou, Hui Li, Wei-Jun Peng, Feng Tang, Zhong-Wei Chen

Published in: Journal of Cancer Research and Clinical Oncology | Issue 9/2005

Login to get access

Abstract

Purpose: To investigate the serial changes of the hepatic metabolites in a chemical-induced rat model of hepatocellular carcinoma (HCC) in vivo by a clinical 1.5 T MR scanner. Methods: Diethyl nitrosamine (DEN) induced HCC model rats (n=60) and control rats (n=20) were included. From week 7 to week 20 after DEN administration, every other week 10–12 animals (8–9 treated and 2–3 controls) were randomly scanned before being sacrificed. According to the pathologic changes, the whole process of tumorigenesis was divided into early and late periods (week 7–13 and week 14–20, respectively). The serial hepatic changes were tested by both routine MRI and single voxel 1H-MRS and compared with pathological results. Point resolved spectroscopy sequence (PRESS) was used for the location in MRS. The integrations of lipid- and choline-containing metabolites were calculated and analyzed. Results: All of the listed tests were fully finished in 66 rats (48 treated and 18 controls). Of the MRS curves, 65.2% (43/66) could be analyzed (mainly with resistant baseline with peaks appearing at right positions). From those qualified MRS curves, there were up to seven peaks which could be identified. The peaks of methylene lipids and methyl lipids were combined together in most cases and became the most notable component. The relative integrals of the combined lipid peak and that of the choline-containing compounds in different groups and stages were measured. Comparing with that of the controls of the same stage, the lipid of treated rats decreased in the late stage, and the choline-containing compounds increased in the same stage. Statistically significant differences were found (P<0.05) for the integrals of the lipid and the choline-containing metabolites between treated and controls in the late stage. Conclusions: Our initial studies for the integrals of the lipid compounds and the choline-containing metabolites might be useful for a better understanding of the metabolic activity of this DEN-induced rat HCC model.
Literature
go back to reference Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM (2001) Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 61:3599–3603PubMed Ackerstaff E, Pflug BR, Nelson JB, Bhujwalla ZM (2001) Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res 61:3599–3603PubMed
go back to reference Allen JR, Prost RW, Griffith OW, Erickson SJ, Erickson BA (2001) In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma. Am J Clin Oncol 24:522–529CrossRefPubMed Allen JR, Prost RW, Griffith OW, Erickson SJ, Erickson BA (2001) In vivo proton (H1) magnetic resonance spectroscopy for cervical carcinoma. Am J Clin Oncol 24:522–529CrossRefPubMed
go back to reference Cance WG, Stewart AK, Menck HR (2000) The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985–1996. Cancer 88:912–920CrossRefPubMed Cance WG, Stewart AK, Menck HR (2000) The National Cancer Data Base Report on treatment patterns for hepatocellular carcinomas: improved survival of surgically resected patients, 1985–1996. Cancer 88:912–920CrossRefPubMed
go back to reference Cho SG, Kim MY, Kim HJ et al (2001) Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 221:740–746PubMedCrossRef Cho SG, Kim MY, Kim HJ et al (2001) Chronic hepatitis: in vivo proton MR spectroscopic evaluation of the liver and correlation with histopathologic findings. Radiology 221:740–746PubMedCrossRef
go back to reference Dixon RM (1998) NMR studies of phospholipid metabolism in hepatic lymphoma. NMR Biomed 11: 370–379CrossRefPubMed Dixon RM (1998) NMR studies of phospholipid metabolism in hepatic lymphoma. NMR Biomed 11: 370–379CrossRefPubMed
go back to reference Foley LM, Towner RA, Painter DM (2001) In vivo image-guided 1 H-magnetic resonance spectroscopy of the serial development of hepatocarcinogenesis in an experimental animal model. Biochim Biophys Acta 1526:230–236PubMed Foley LM, Towner RA, Painter DM (2001) In vivo image-guided 1 H-magnetic resonance spectroscopy of the serial development of hepatocarcinogenesis in an experimental animal model. Biochim Biophys Acta 1526:230–236PubMed
go back to reference Galli C, Rise P, Marangoni F et al (1997) Manipulation of the fate of long chain polyunsaturated fatty acids in cultured cells. Prostaglandins Leukot Essent Fatty Acids 57:23–26CrossRefPubMed Galli C, Rise P, Marangoni F et al (1997) Manipulation of the fate of long chain polyunsaturated fatty acids in cultured cells. Prostaglandins Leukot Essent Fatty Acids 57:23–26CrossRefPubMed
go back to reference Ha WS, Kim CK, Song SH, Kang CB (2001) Study on mechanism of multistep hepatotumorigenesis in rat: development of hepatotumorigenesis. J Vet Sci 2:53–58PubMed Ha WS, Kim CK, Song SH, Kang CB (2001) Study on mechanism of multistep hepatotumorigenesis in rat: development of hepatotumorigenesis. J Vet Sci 2:53–58PubMed
go back to reference Hasumi M, Suzuki K, Oya N, Ito K, Kurokawa K, Fukabori Y, Yamanaka H (2002) MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer. Anticancer Res 22:1205–1208PubMed Hasumi M, Suzuki K, Oya N, Ito K, Kurokawa K, Fukabori Y, Yamanaka H (2002) MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer. Anticancer Res 22:1205–1208PubMed
go back to reference Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA (2004) Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 19:68–75CrossRefPubMed Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA (2004) Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 19:68–75CrossRefPubMed
go back to reference Kumar A, Kaushik S, Tripathi RP, Kaur P, Khushu S (2003) Role of in vivo proton MR spectroscopy in the evaluation of adult brain lesions: our preliminary experience. Neurol India 51:474–478PubMed Kumar A, Kaushik S, Tripathi RP, Kaur P, Khushu S (2003) Role of in vivo proton MR spectroscopy in the evaluation of adult brain lesions: our preliminary experience. Neurol India 51:474–478PubMed
go back to reference Kuo YT, Li CW, Chen CY et al (2004) In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging 19:598–604CrossRefPubMed Kuo YT, Li CW, Chen CY et al (2004) In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner. J Magn Reson Imaging 19:598–604CrossRefPubMed
go back to reference Lim AK, Patel N, Gedroyc WM, Blomley MJ, Hamilton G, Taylor-Robinson SD (2002) Hepatocellular adenoma: diagnostic difficulties and novel imaging techniques. Br J Radiol 75:695–699PubMed Lim AK, Patel N, Gedroyc WM, Blomley MJ, Hamilton G, Taylor-Robinson SD (2002) Hepatocellular adenoma: diagnostic difficulties and novel imaging techniques. Br J Radiol 75:695–699PubMed
go back to reference Lim AK, Patel N, Hamilton G, Hajnal JV, Goldin RD, Taylor-Robinson SD (2003) The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 37:788–794CrossRefPubMed Lim AK, Patel N, Hamilton G, Hajnal JV, Goldin RD, Taylor-Robinson SD (2003) The relationship of in vivo 31P MR spectroscopy to histology in chronic hepatitis C. Hepatology 37:788–794CrossRefPubMed
go back to reference Mahon MM, Cox IJ, Dina R, Soutter WP, McIndoe GA, Williams AD, deSouza NM (2004) 1H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: In vivo-Ex vivo profiles and effect of tumor load. J Magn Reson Imaging 19:356–364CrossRefPubMed Mahon MM, Cox IJ, Dina R, Soutter WP, McIndoe GA, Williams AD, deSouza NM (2004) 1H magnetic resonance spectroscopy of preinvasive and invasive cervical cancer: In vivo-Ex vivo profiles and effect of tumor load. J Magn Reson Imaging 19:356–364CrossRefPubMed
go back to reference Rise P, Marangoni F, Galli C (2002) Regulation of PUFA metabolism: pharmacological and toxicological aspects. Prostaglandins Leukot Essent Fatty Acids 67:85–89CrossRefPubMed Rise P, Marangoni F, Galli C (2002) Regulation of PUFA metabolism: pharmacological and toxicological aspects. Prostaglandins Leukot Essent Fatty Acids 67:85–89CrossRefPubMed
go back to reference Schafer DF, Sorrell MF (2001) Hepatocellular carcinoma 353:1253–1257 Schafer DF, Sorrell MF (2001) Hepatocellular carcinoma 353:1253–1257
go back to reference Star-Lack JM, Adalsteinsson E, Gold GE, Ikeda DM, Spielman DM (2000) Motion correction and lipid suppression for 1h magnetic resonance spectroscopy. Magn Reson Med 43:325–330CrossRefPubMed Star-Lack JM, Adalsteinsson E, Gold GE, Ikeda DM, Spielman DM (2000) Motion correction and lipid suppression for 1h magnetic resonance spectroscopy. Magn Reson Med 43:325–330CrossRefPubMed
go back to reference Tarasow E, Siergiejczyk L, Panasiuk A, Kubas B, Dzienis W, Prokopowicz D, Walecki J (2002) MR proton spectroscopy in liver examinations of healthy individuals in vivo. Med Sci Monit 8:MT36–MT40PubMed Tarasow E, Siergiejczyk L, Panasiuk A, Kubas B, Dzienis W, Prokopowicz D, Walecki J (2002) MR proton spectroscopy in liver examinations of healthy individuals in vivo. Med Sci Monit 8:MT36–MT40PubMed
go back to reference Taylor-Robinson SD, Sargentoni J, Bell JD et al (1997) In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver 17:198–209PubMed Taylor-Robinson SD, Sargentoni J, Bell JD et al (1997) In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver 17:198–209PubMed
Metadata
Title
In vivo detection of metabolic changes by 1 H-MRS in the DEN-induced hepatocellular carcinoma in wistar rat
Authors
Wei-Dong Zhao
Sheng Guan
Kang-Rong Zhou
Hui Li
Wei-Jun Peng
Feng Tang
Zhong-Wei Chen
Publication date
01-09-2005
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 9/2005
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-005-0684-x

Other articles of this Issue 9/2005

Journal of Cancer Research and Clinical Oncology 9/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.